Linc AB
LINC.ST
| Exchange: | ST |
| Currency | Swedish krone |
| ISIN: | SE0015949433 |
| Primary Ticker: | LINC.ST |
| Fiscal Year End: | December |
| Sector: | Financial Services |
| Industry: | Asset Management |
| Gic Sector: | Industrials |
| Gic Group: | Commercial & Professional Services |
| Gic Industry: | Commercial Services & Supplies |
| Gic Sub Industry: | Environmental & Facilities Services |
| Description: | Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.99 million), the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB was founded in 1991 and based in Stockholm, Sweden. |
| Address: | Vasagatan 28, Stockholm, Sweden, 111 20 |
| Website: | https://linc.se |
| Full Time Employees: | 2 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 4545966592 |
| Market Capitalization Mln: | 4545.96 |
| PE Ratio: | 6.35 |
| Book Value: | 79.77 |
| Earnings Share: | 12.36 |
| Most Recent Quarter: | 2024-09-30 |
| Profit Margin: | 1.00 |
| Operating Margin TTM: | 1.14 |
| Return On Assets TTM: | 0.25 |
| Return On Equity TTM: | 0.41 |
| Revenue TTM: | 1570461056 |
| Revenue Per Share TTM: | 27.11 |
| Quarterly Revenue Growth YOY: | -0.81 |
| Gross Profit TTM: | -892228000 |
| Diluted Eps TTM: | 12.36 |
| Quarterly Earnings Growth YOY: | -0.78 |
Valuation
| Trailing PE: | 6.35 |
| Price Sales TTM: | 2.89 |
| Price Book MRQ: | 0.99 |
| Enterprise Value: | 3029001402 |
| Enterprise Value Revenue: | 1339.95 |
| Enterprise Value Ebitda: | 1.91 |
Shares
| Shares Outstanding: | 57910400 |
| Shares Float: | 21095618 |
| Percent Insiders: | 64.28 |
| Percent Institutions: | 26.48 |
Technicals
| Beta: | 0.97 |
| 52 Week High: | 103.4 |
| 52 Week Low: | 52.2 |
| 50 Day MA: | 84.81 |
| 200 Day MA: | 78.72 |
Earnings
| Report Date: | 2025-05-15 |
| Date: | 2025-03-31 |
| Before After Market: | After Market |
| Currency: | SEK |
| Report Date: | 2024-09-30 |
| Date: | 2024-09-30 |
| Currency: | SEK |
| Eps Actual: | -0.20 |
| Report Date: | 2024-06-30 |
| Date: | 2024-06-30 |
| Currency: | SEK |
| Eps Actual: | 17.97 |
| Report Date: | 2024-05-15 |
| Date: | 2024-03-31 |
| Before After Market: | After Market |
| Currency: | SEK |
| Eps Actual: | 1.05 |
| Report Date: | 2023-12-31 |
| Date: | 2023-12-31 |
| Currency: | SEK |
| Eps Actual: | 8.47 |
| Report Date: | 2023-09-30 |
| Date: | 2023-09-30 |
| Currency: | SEK |
| Eps Actual: | -0.67 |
| Report Date: | 2023-06-30 |
| Date: | 2023-06-30 |
| Currency: | SEK |
| Eps Actual: | -1.93 |
| Report Date: | 2023-03-31 |
| Date: | 2023-03-31 |
| Currency: | SEK |
| Eps Actual: | 4.83 |
| Report Date: | 2022-12-31 |
| Date: | 2022-12-31 |
| Currency: | SEK |
| Eps Actual: | 1.75 |
| Report Date: | 2022-09-30 |
| Date: | 2022-09-30 |
| Currency: | SEK |
| Eps Actual: | -0.88 |
| Report Date: | 2022-06-30 |
| Date: | 2022-06-30 |
| Currency: | SEK |
| Eps Actual: | -6.38 |
| Report Date: | 2022-03-31 |
| Date: | 2022-03-31 |
| Currency: | SEK |
| Eps Actual: | -6.98 |
| Report Date: | 2021-12-31 |
| Date: | 2021-12-31 |
| Currency: | SEK |
| Eps Actual: | 0.29 |
| Report Date: | 2021-09-30 |
| Date: | 2021-09-30 |
| Currency: | SEK |
| Eps Actual: | 1.39 |
| Report Date: | 2021-06-30 |
| Date: | 2021-06-30 |
| Currency: | SEK |
| Eps Actual: | -2.05 |
| Date: | 2024-09-30 |
| Eps Actual: | 18.83 |
| Date: | 2023-12-31 |
| Eps Actual: | 10.69 |
| Date: | 2022-12-31 |
| Eps Actual: | -12.49 |
| Date: | 2021-12-31 |
| Eps Actual: | -0.36 |